Benign Prostatic Hyperplasia - Pipeline Review, H2 2012 New Report
Benign Prostatic Hyperplasia - Pipeline Review, H2 2012, provides an overview of the Benign Prostatic Hyperplasia therapeutic pipeline. This report provides information on the therapeutic development for Benign Prostatic Hyperplasia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Benign Prostatic Hyperplasia. 'Benign Prostatic Hyperplasia - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC...
View full press release